YKYoshiki Kawamura

Yoshiki Kawamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yoshiki Kawamura has a total of 215 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Respiratory Pathogen Detection in Pediatric Asthma Exacerbations Using the FilmArray Respiratory Panel 2.1

    by Masato Itano, Yoshiki Kawamura, Takahiro Matsuno, Natsuki Hatakawa, Katsuyuki Yokoi, Akiko Otake, Yuji Mori, Yoichi Nakajima, Yotaro Kondo, Hiroki Miura, et al.

    Viral infections, particularly rhinoviruses (RVs) and respiratory syncytial virus (RSV), are major causes of pediatric acute asthma exacerbations. The FilmArray Respiratory Panel 2.1 (FARP2.1) is an automated multiplex PCR tool that is being increasingly used in clinical settings; however, its application in asthma exacerbations has not been studied yet. From April 2022 to March 2025, children aged between 6 months and 5 years who had been hospitalized for asthma exacerbations were enrolled (“asthma group,” n = 67), alongside children with respiratory infections without wheezing within the same age range (“non‐asthma group,” n = 207). Nasopharyngeal swabs were performed in all, tested with FARP2.1, and all detected pathogens and clinical features were compared between the two groups. RV/enterovirus (EV) prevalence was significantly higher in the asthma group (82.1%) than in the non‐asthma group (28.5%). RSV prevalence was similar in both groups (19.4% vs. 30.0%), while parainfluenza virus was more frequent in the non‐asthma group (11.9% vs. 24.2%). The peaks in asthma hospitalizations coincided with RV/EV detection peaks during the autumn. These results highlight that RV/EV was significantly associated with pediatric asthma exacerbations, frequently occurring. Although typically a cause of the common cold, RV/EV may represent an important trigger of asthma exacerbation in children.

  • A Patient-Derived iPSC-based Model Reveals Neural Lineage-Specific Transcription of Endogenous HHV-6B

    by Hiroki Miura, Tomoki Inagaki, Tamae Ohye, Akiko Yoshikawa, Takayuki Murata, Naoki Yahata, Yoshiki Kawamura, Yotaro Kondo, Jun-Ichi Kawada, Masaru Ihira, et al.

    Background: Endogenous human herpesvirus 6 (eHHV-6), in which the entire viral genome is integrated into human chromosomes, is present in approximately 1% of the population and has been associated with various clinical conditions, including neurological disorders. However, its biological significance remains unclear due to the lack of appropriate experimental models. Methods: We established a patient-derived induced pluripotent stem cell (iPSC)–based tissue culture model using lymphoblastoid cell lines from individuals with eHHV-6B. iPSCs retaining the integrated viral genome were generated and subsequently differentiated into neural stem cells (NSCs). Viral gene expression was evaluated by RT-qPCR under basal conditions and following chemical stimulation. Results: The integrated HHV-6B genome was transcriptionally silent in iPSCs but exhibited spontaneous low-level expression of the immediate-early gene U90 and the late gene U100 in NSCs. Chemical stimulation further enhanced U90 expression, whereas induction of U100 did not reach statistical significance. These findings indicate preferential activation of early viral transcriptional programs in neural lineage cells. Conclusions: Neural lineage cells provide a permissive environment for expression of eHHV-6B transcripts. This patient-derived iPSC-based model provides a platform for investigating the biological significance of neural lineage-specific eHHV-6 transcripts and may facilitate interpretation of HHV-6 DNA detection in patients with eHHV-6 by enabling studies of cell type-dependent viral transcription.

  • Single-Cell RNA Sequencing Reveals Distinct Immune Interaction Networks in Primary and Reactivated HHV-6B Infection

    by Yoshiki Kawamura, Yoshitaka Sato, Yusuke Tsumura, Manabu Wakamatsu, Shiori Endo, Takako Suzuki, Yotaro Kondo, Masato Itano, Hiroki Miura, Yuki Higashimoto, et al.

    Background: Human herpesvirus 6B (HHV-6B) infection causes clinically distinct diseases in primary infection or viral reactivation. Primary infection manifests as exanthem subitum (ES), a common childhood febrile exanthem; whereas reactivation is associated with drug reaction with eosinophilia and systemic symptoms (DRESS), a severe cutaneous adverse reaction. The immune mechanisms underlying these divergent outcomes remain poorly understood. Methods: We performed single-cell RNA sequencing of peripheral blood mononuclear cells from patients with ES and DRESS. Comparative analysis of immune cell populations and transcriptional programs during the acute and recovery phases revealed distinct immune interaction networks. Results: Primary HHV-6B infection was characterized by marked expansion of proliferating natural killer (NK) cells, which expressed cytotoxic effector genes including GNLY and NKG7. Cell–cell communication analysis predicted strong communication between proliferating NK cells and inflammatory monocytes during acute ES. In contrast, HHV-6B reactivation in DRESS was associated with expansion of proliferating CD4+ T cells with inflammatory transcriptional signatures that showed predicted communication with CD14+ monocytes. Despite these differences, monocytes occupied a prominent position within the predicted interaction networks in both conditions. Complementary protein-level analysis identified CXCL10 as a shared systemic inflammatory marker in active HHV-6B infection. Conclusions: HHV-6B infection exhibits distinct immune interaction networks depending on the clinical context, characterized by proliferating NK cell–monocyte interactions during primary infection and proliferating CD4+ T cell–monocyte interactions during viral reactivation.

  • Open Access

    Comprehensive Viral Detection and Profiling of Plasma Cell‐Free RNA in Patients With Suspected Hemophagocytic Lymphohistiocytosis

    by Yuto Fukuda, Kazuhiro Horiba, Masanori Hashino, Shinji Kawabe, Hiroki Miura, Yoshiki Kawamura, Makito Tanaka, Takako Suzuki, Yuka Torii, Hideki Muramatsu, et al.

    Hemophagocytic lymphohistiocytosis (HLH) is a severe, rapidly progressive disease. While viral infection is considered a common etiology of pediatric HLH, specific causative viruses other than the Epstein‐Barr virus (EBV) have been rarely identified. This study utilized metagenomic next‐generation sequencing (NGS) to identify potential causative pathogens in plasma samples from 17 pediatric patients with suspected HLH. Additionally, one case each of confirmed EBV‐ and cytomegalovirus (CMV)‐associated HLH was analyzed for methodological validation. Plasma cell‐free RNA (cfRNA) profiling was performed using NGS data to assess the host transcriptome response. Significant viral reads of human herpesvirus‐6B, human herpesvirus‐7, and Hubei reo‐like virus (HRLV) 14 were detected using metagenomic NGS in one patient each. Plasma cfRNA profiles from five patients with viral infection (including EBV and CMV) were compared to those of 14 patients without viral infection. By comparing the two patient groups, 1053 differentially expressed genes were identified. The gene ontology (GO) term of “adaptive immune response” (GO: 0002250) was significantly enriched among upregulated genes in the virus‐positive group. Furthermore, an isolated cluster consisting specifically of mitochondrial RNAs, was identified in the upregulated genes of the virus‐positive group. Using metagenomic NGS, several candidate viral pathogens were identified in patients with suspected infection‐related HLH. The viral genome of HRLV 14, previously undetected in human clinical samples, was identified in one patient. The results from plasma cfRNA profiling suggest that mitochondrial RNAs may reflect the underlying pathogenesis of virus‐associated HLH and have potential utility as disease biomarkers.

  • Open Access

    Identification of Murine Rotavirus Virulence Determinants Using Bidirectional Selective Passaging and a Reverse Genetics System

    by Saori Fukuda, Masanori Kugita, Yuki Akari, Johannes M. Dijkstra, Yoshiki Kawamura, Shizuko Nagao, Tetsushi Yoshikawa, Takayuki Murata, Satoshi Komoto

    Live-attenuated rotavirus (RV) vaccines are the most effective interventions for preventing RV gastroenteritis (RVGE) in young children. However, the molecular basis of attenuation remains not well understood. Here, we describe a compact but comprehensive strategy to identify RV virulence determinants by combining low-passage bidirectional selection, sequence analysis, and segment-level phenotype testing via a reverse genetics infectious system. Using the virulent murine RV strain EW, virulence was quantified by diarrhea severity/duration and body-weight gain. Serial passaging in cell culture selected an attenuated population, which regained virulence after passaging in suckling mice. Sequence comparison of the virulent and attenuated EW populations revealed only seven amino acid differences. We summarized literature describing attenuation/virulence-associated mutations in various RV group A (RVA) strains and found previous findings identical or similar to four of the seven mutations: NSP4-T45M, VP4-S470L, VP4-T612A, and VP7-T75P. Virulent- and attenuated-type EW variants of VP2, VP4, VP7, and NSP4 were introduced individually, or as NSP4/VP7 or VP4/VP7 pairs, into a simian SA11-L2 backbone using an 11-plasmid reverse genetics system. Phenotyping of rescued viruses consistently linked cell-culture–adapted VP4 to enhanced replication in vitro and reduced virulence in suckling mice. In vivo passaging strongly favored VP4 residue S470 over cell-culture-selected L470. More generally, our findings (i) underscore VP4 and VP7 as key determinants of EW virulence, (ii) provide a practical framework for identifying driver mutations underlying RVA attenuation, and (iii) highlight attenuation-associated substitutions shared across diverse RVAs.

  • Open Access

    A viral APOBEC3 antagonist distinguishes HHV-6A from HHV-6B

    by Jun Arii, Salma Aktar, Jing Rin Huang, Mansaku Hirai, Yoshiki Kawamura, Hiroki Miura, Bochao Wang, Satoshi Nagamata, Mitsuhiro Nishimura, Tetsushi Yoshikawa, et al.

    Human herpesviruses exhibit diverse pathogenic outcomes and the molecular reasons are not fully understood. Human herpesvirus 6B (HHV-6B) causes exanthema subitum and encephalitis, whereas the closely related HHV-6A is typically asymptomatic. Here, we show that cellular APOBEC3 enzymes restrict HHV-6A replication but not HHV-6B. HHV-6B expresses higher levels of the U28 protein, which binds multiple APOBEC3 proteins and promotes their relocalization and degradation. In contrast, HHV-6A fails to counteract APOBEC3 activity and accumulates extensive mutations in both cell- and patient-derived viral genomes. Individual APOBEC3 gene ablation enhances HHV-6A replication and reduces the viral mutation burden. Together, our studies suggest that differential susceptibility to APOBEC3 restriction may help to shape the evolvability and clinical manifestations of HHV-6A and HHV-6B.


  • Open Access

    Proteomic Analysis of Serum and Cerebrospinal Fluid in Children with Encephalopathy Associated with Human Betaherpesvirus 6B

    by Yoshiki Kawamura, Hisateru Yamaguchi, Tomoki Nishioka, Mao Kiribuchi, Ayano Yun, Hiroki Miura, Yotaro Kondo, Masato Itano, Yuki Higashimoto, Masaru Ihira, et al.

    Background: Exanthem subitum (ES), a benign febrile exanthematous disease, is caused by primary human betaherpesvirus 6B (HHV-6B) infection. It may cause neurological complications, including complex febrile seizures (cFS), acute encephalopathy with biphasic seizures, and late reduced diffusion (AESD). cFS resolves spontaneously; however, AESD can pose severe sequelae. We aimed to elucidate AESD pathogenesis using a proteomic analysis. Methods: Using liquid chromatography-tandem mass spectrometry (LC-MS/MS), serum and cerebrospinal fluid (CSF) protein profiles were compared between patients with AESD and those with cFS (n = 3 or 4 per group). Metascape was used for enrichment analysis, and the selected proteins were validated using a large sample via enzyme-linked immunosorbent assay (ELISA). Results: A total of 698 proteins were identified across all serum and CSF samples using LC-MS/MS. Nineteen serum proteins were differentially expressed in AESD and cFS during the acute phase. The glycolytic pathway was upregulated in AESD. Myristoylated alanine-rich C kinase substrate (MARCKS) and Golgi membrane protein 1 (GOLM1) were selected for validation using ELISA. Both proteins were upregulated during the acute phase (n = 11) compared with the convalescent phase (n = 21) in AESD (MARCKS, P = .016; GOLM1, P < .001). MARCKS during the acute phase was also upregulated in AESD compared with that in uncomplicated ES (n = 15) (P = .015). In CSF, 38 proteins were differentially expressed between AESD and cFS during the acute phase. Cholesteryl ester transfer protein in the CSF of patients with AESD was upregulated; however, this could not be validated using ELISA. Conclusions: Glycolysis and MARCKS pathways might be involved in HHV-6B-associated AESD pathogenesis.

  • Hippocampal Gene Expression in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis: Assessment of Human Herpesvirus 6B DNA Status

    by Yoshiki Kawamura, Yuki Higashimoto, Keisuke Hitachi, Rena Ishihara, Taiga Kudo, Hiroki Miura, Kazuhiro Horiba, Jun‐Ichi Kawada, Masaru Ihira, Yukitoshi Takahashi, et al.

    Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is an intractable form of epilepsy involving the hippocampus, and temporal lobectomy remains an effective treatment. Human herpesvirus 6B (HHV‐6B) establishes latency in the hippocampus and may contribute to MTLE‐HS pathogenesis by altering host gene expression; however, transcriptomic data from healthy controls remain limited. This study investigated the role of HHV‐6B to MTLE‐HS pathogenesis by analyzing gene expression in resected hippocampal tissues. Samples were collected from 12 to 43 HHV‐6 DNA‐positive and ‐negative patients, respectively, and three controls. RNA sequencing was performed on eight representative samples, followed by RT‐qPCR validation of nine selected genes in 58 samples. RNA sequencing identified 600 differentially expressed genes (210 upregulated, 390 downregulated) between HHV‐6B‐positive MTLE‐HS and controls. Pathway enrichment analysis revealed involvement of synaptic signaling and inflammatory responses, with prostaglandin biosynthesis specifically upregulated in HHV‐6B‐positive tissues. Two genes were significantly upregulated in HHV‐6B‐positive compared with HHV‐6B‐negative samples. RT‐qPCR confirmed elevated cholesterol 25‐hydroxylase and interleukin 1 beta expression in HHV‐6 DNA‐positive samples (both p = 0.031). These findings suggest that HHV‐6B may contribute to MTLE‐HS pathogenesis by modulating the expression of host inflammatory genes, supporting a role for neuroinflammation and the potential benefits of anti‐inflammatory therapies.


  • Association of Rotavirus Infection With Biliary Atresia: A Retrospective Comparative Analysis of Virus‐Specific Antibodies

    by Yoshiki Kawamura, Masaru Ihira, Yuki Higashimoto, Toshihiro Yasui, Koichi Ito, Mitsuyoshi Suzuki, Nobuhiko Nagano, Katsumi Yoshizawa, Hiroki Miura, Jun‐Ichi Kawada, et al.

    Background: Biliary atresia (BA) is a severe infantile hepatobiliary disorder of unknown etiology. Perinatal rotavirus (RV) infection has been implicated in animal models of BA; however, supporting human data remains limited. The study investigated the serological evidence of recent RV infection in infants with BA using RV‐specific immunoglobulin (Ig)‐A, a marker of primary infection unaffected by maternal antibodies. Methods: Serum samples from 17 infants with BA and 30 age‐matched controls without gastrointestinal symptoms or prior RV vaccination were retrospectively analyzed. Anti‐RV‐IgA titers were measured by enzyme‐linked immunosorbent assay using purified WA‐strain virions. Cytomegalovirus (CMV)‐IgM and Epstein‐Barr virus (EBV)‐viral capsid antigen (VCA)‐IgM levels were assessed using commercial enzyme immunoassays. Results: RV‐IgA was detected in 70.6% (12/17) of the patients with BA versus 3.4% (1/29) of the controls ( p < 0.001). RV‐IgA titers were significantly higher in the BA group (median: interquartile range 2 8.0 :2 6.0 –2 10.0 ) than in the control group (2 3.5 :2 2.0 –2 4.8 ) ( p = 0.004). Among patients diagnosed with BA after 14 days of age, 84.6% (11/13) were RV‐IgA‐positive. CMV‐IgM was detected in three patients in the BA group and one individual in the control group, while EBV‐VCA‐IgM was negative in BA patients and positive in two controls; neither difference was statistically significant. Conclusions: The study findings support the potential association between RV infection and BA pathogenesis. However, the lack of an epidemiological reduction in BA following the introduction of the RV vaccine warrants caution in other studies. Further prospective multicenter studies are required to elucidate the causal role of RV infection in BA development.


  • Investigation of anti-N-methyl-D-aspartate receptor and anti-myelin oligodendrocyte glycoprotein antibodies in patients with human herpesviruses-associated central nervous system infections

    by Soichiro Ishimaru, Yoshiki Kawamura, Hiroshi Sakuma, Sayuri Shima, Hiroki Miura, Akihiro Ueda, Hirohisa Watanabe, Tatsuro Mutoh, Tetsushi Yoshikawa

    Human herpesviruses (HHVs) cause central nervous system (CNS) infections; however, the role of neural autoantibodies remains unclear. We aimed to assess the presence of anti-N-methyl-D-aspartate receptor (anti-NMDAR) and anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in HHV-associated CNS infections. Seventeen adults with HHV DNA in the cerebrospinal fluid were tested using flow cytometry-based assays. None of the patients tested positive for anti-NMDAR antibodies. Anti-MOG antibodies were detected in two patients with VZV-associated CNS infection, one appearing after deterioration and the other at onset. Both patients recovered without sequelae. Anti-MOG antibodies may arise in VZV-associated CNS infections, warranting the consideration of autoimmune mechanisms.